MDACC protocol
protocol of alternating high doses of cyclophosphamide & methotrexate, with cytarabine & hydrocortisone coordinated with the methotrexate; used for Burkitt's lymphoma and advanced nonlymphoblastic lymphoma in children
Also Known As:
M.D. Anderson Cancer Center protocol
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Therapy Context: Research Results
Experts
1. | Kapoor, Rakesh:
1 article
(01/2020)
|
2. | Khandelwal, Niranjan:
1 article
(01/2020)
|
3. | Khosla, Divya:
1 article
(01/2020)
|
4. | Kumar, Narendra:
1 article
(01/2020)
|
5. | Kumar, Ridu:
1 article
(01/2020)
|
6. | Madan, Renu:
1 article
(01/2020)
|
7. | Miriyala, Raviteja:
1 article
(01/2020)
|
8. | Mukherjee, Anindya:
1 article
(01/2020)
|
9. | Oinam, Arun S:
1 article
(01/2020)
|
10. | Sharma, Suresh C:
1 article
(01/2020)
|